SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is actively trending amidst a surge of community mentions and engagement, reflecting both strong bullish sentiment and ongoing technical discussions. Many compare it to Bitcoin, highlighting its potential as a faster, cheaper 'digital silver' for transactions, though some long-term holders express skepticism about its performance.

The White Whale

WHITEWHALE CRYPTO is generating significant community discussion, driven by reports of relentless volume, massive accumulation, and strong price action, particularly within the Solana meme coin ecosystem. Investors are pointing to its substantial market cap growth and unique tokenomics, including a significant portion of its supply locked until 2063, as key factors distinguishing its perceived legitimacy. The overall sentiment suggests a belief in its continued upward trajectory, drawing comparisons to other high-performing meme assets.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid intense debate surrounding the former president's reported intentions regarding Greenland and Venezuela's oil resources, alongside highly contentious discussions about domestic law enforcement actions. The community is sharply polarized, with supporters applauding perceived strong economic plans and decisive leadership, while critics voice alarm over alleged authoritarianism and potentially reckless foreign policy. This deep political division directly fuels conversation around the stock, reflecting broader geopolitical and domestic tensions.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

The $DOG ticker is predominantly trending due to significant community interest in a Bitcoin-native memecoin named 'DOG GO TO THE MOON,' rather than solely the ProShares Short Dow30 ETF it officially represents. Enthusiasts are actively discussing its fair launch, decentralized nature, and perceived potential as a major cryptocurrency, with many advocating for broader exchange listings.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is trending due to active community discussion surrounding its pivotal tokenomics redesign, which aims to transition from inflationary rewards to a revenue-based model. Many investors are buying and staking for attractive yields, anticipating significant long-term growth and potential for new price highs as the "Internet of Blockchains" ecosystem expands. Despite mixed sentiment from past performance, there's renewed focus on ATOM's fundamental role and potential for a bullish breakout amidst broader altcoin market optimism.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

United States Natural Gas Fund ($UNG) is heavily discussed as traders react to forecasts of arctic air and a polar vortex impacting the U.S., driving expectations for increased heating demand. This potential cold snap sparks debate, with many viewing recent price dips as a buying opportunity given tightening storage and strong LNG exports, while others caution about the commodity's historical volatility and high production levels. Additionally, the growing energy demands from AI data centers are emerging as a new long-term bullish narrative, adding another layer to the complex outlook for natural gas.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending with significant community excitement driven by rising trading volume and technical breakouts, as investors anticipate major developments in its Layer-2 mainnet, decentralized AI, DePIN, and secure data monetization. Holders are expressing strong conviction about the project's utility and potential for substantial growth, especially within Japan's evolving digital landscape and a broader "altcoin season" outlook.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is trending following a strong earnings report and raised guidance, further boosted by community discussion around recent coffee tariff reductions which could enhance margins. This news, coupled with consistent reports of robust new store openings and high customer demand, especially from its loyal Gen Z base, fuels positive community sentiment and analyst upgrades. Strategic expansion into grocery retail and new food offerings are also highlighted as potential long-term growth pillars, contributing to active bullish conversations despite some valuation concerns.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors keenly await its FDA Biologics License Application (BLA) resubmission for Deramiocel, following robust Phase 3 HOPE-3 data for Duchenne Muscular Dystrophy. Bulls express strong conviction in the "stat sig" results, anticipating accelerated approval and significant upside, yet community dialogue also highlights growing impatience over the delayed submission and concerns among some about potential regulatory scrutiny, driving current market fluctuations. This tension between strong data and perceived communication delays fuels active discussion surrounding the company's future in the DMD therapeutic landscape.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending amid widespread discussion surrounding a proposed interest rate cap on credit cards, which is sparking varied reactions across the financial sector. Many in the community believe this could ironically benefit SoFi by driving consumers towards its personal loan products and diversified financial services, a sentiment reinforced by its CEO. This ongoing debate highlights SoFi's agile positioning relative to traditional banks as it approaches its anticipated earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations

AMRN jumps 17% after Q4 and FY2025 preliminary sales beat expectations. The release also reflected positive Q4 cash flow and progress on cost cuts.

Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress

Bayer AG enters into collaborations to develop a heart-targeted siRNA therapy and AI technology, expanding its push into next-gen genetic medicines. 

Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their...

GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug

Monte Rosa shares surge 45% after interim phase I data show that MRT-8102 drives deep NEK7 degradation and reduces sharp inflammation markers.

KRYS Stock Surges 57% in a Year: More Upside Potential in 2026?

Shares of Krystal Biotech soar 57% in a year as strong Vyjuvek uptake and steady pipeline progress continue to push the stock higher.

EXEL Collaborates With Natera for Late-Stage Colorectal Cancer Study

Exelixis teamed with Natera on the phase III STELLAR-316 study testing zanzalintinib in resected stage II/III colorectal cancer. Stock gains. 



OTLK Stock Crashes 67% in a Week: Here's What You Need to Know

Outlook Therapeutics stock plunges 67% in a week after the FDA issues a third CRL rejecting its ONS-5010 BLA for wet AMD, again seeking confirmatory data.

Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase?

CELC shares surge as NDA filing and strong phase III data boost optimism around gedatolisib's potential.

Will Galafold Be Able to Aid FOLD's Top Line Heading Into Q4 Earnings?

Galafold drives over 80% of Amicus product revenues, with $371.5M in the first nine months of 2025 sales as investors await Q4 sales performance.

Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their...

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Amicus Therapeutics Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$14.28
Prev Close	$14.28
Open	$14.28
Dividend Yield	0.00%
50-Day Moving Average	$10.96
Beta	0.84
Avg. Volume	16.2M
PE Ratio	-319.46

52-Week High	$14.36
52-Week Low	$5.51
Market Capitalization	$4.42B
EPS (Annual)	-$0.1843
Price to Book	19.12
Revenue Per Employee	$1.06M
Enterprise Value/EBITDA	N/A

FOLD
Amicus Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FOLD News

FOLDAmicus Therapeutics Inc